Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4001 Rainbow Blvd
Stop 4033
Kansas City, KS 66160Phone+1 913-588-3600Fax+1 913-588-3663
Summary
- Dr. Ronald Chen is a radiation oncologist in Kansas City, KS. He received his medical degree from Harvard Medical School and has been in practice 13 years. He is experienced in brachytherapy, prostate cancer, stereotactic radiosurgery, intensity-modulated radiation therapy, and radiosurgery.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2005 - 2009
- Massachusetts General HospitalInternship, Internal Medicine, 2004 - 2005
- Harvard Medical SchoolClass of 2004
Certifications & Licensure
- NM State Medical License 2023 - 2027
- IA State Medical License 2023 - 2026
- NE State Medical License 2023 - 2026
- CO State Medical License 2022 - 2025
- KS State Medical License 2019 - 2025
- MO State Medical License 2019 - 2025
- NC State Medical License 2009 - 2020
- American Board of Radiology Radiation Oncology
- Join now to see all
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy Start of enrollment: 2012 Jun 01
- Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer Start of enrollment: 2013 Oct 01
- Using PROMIS as Part of Routine Clinical Care for Racially Diverse Prostate and Bladder Cancer Patients Start of enrollment: 2017 May 08
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsHigh Dose "HDR-Like" Prostate SBRT: PSA 10-Year Results From a Mature, Multi-Institutional Clinical Trial.Donald B Fuller, Tami Crabtree, Brent L Kane, Clinton A Medbery, Robert Pfeffer
Frontiers in Oncology. 2022-01-01 - 275 citationsActive Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline ...Ronald C. Chen, R. Bryan Rumble, D. Andrew Loblaw, Antonio Finelli, Behfar Ehdaie
Journal of Clinical Oncology. 2016-09-27 - 11 citationsAsymmetric multi-task attention network for prostate bed segmentation in computed tomography images.Xuanang Xu, Chunfeng Lian, Shuai Wang, Tong Zhu, Ronald C. Chen
Medical Image Analysis. 2021-05-28
Lectures
- Health Services Research, Clinical Informatics, and Quality of CareASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
- Quality-adjusted time without symptoms or toxicity (Q-TWiST): Analysis of cabozantinib (Cabo) vs sunitinib (Sun) in patients with advanced renal cell carcinoma (aRCC) ...2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
- Frequency of post-treatment surveillance and survival in localized prostate cancer: AFT-30 a national study.2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
Press Mentions
- KU Cancer Center Uses Art to Reach Underprivileged CommunitiesFebruary 22nd, 2023
- KU Cancer Center Uses Art to Reach Underserved CommunitiesFebruary 21st, 2023
- NRG Oncology Trial Aimed to Improve Prostate Cancer Survivor Care Planning Reaches Accrual GoalJuly 29th, 2022
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: